AMS – Family Medicine – Rheumatology: Rheumatoid Arthritis; Spondyloarthropothies; Scleroderma and Raynaud’s Disease

$119.00$189.00

$189.00
$119.00
StreamingINCLUDED FREE

Topics and Objectives

Title: Family Medicine – Rheumatology: Rheumatoid Arthritis; Spondyloarthropothies; Scleroderma and Raynaud’s Disease
Faculty: William T. Ayoub, M.D., F.A.C.P., F.A.C.R., Lawrence H. Brent, M.D.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Rheumatoid Arthritis: Clinical Manifestations and Treatment.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical features of rheumatoid arthritis.
  2. Illustrate the systemic nature of the disease.
  3. Summarize the use and toxicity of disease modifying agents as recommended by the American College of Rheumatology guidelines.

TOPIC 2: Spondyloarthropathies.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
  2. Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
  3. Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

TOPIC 3: Scleroderma and Raynaud’s Disease.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical manifestations of scleroderma.
  2. Apply the ACR/EULAR classification criteria for systemic sclerosis.
  3. Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
  4. Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

Total Cost: $

Title: Family Medicine – Rheumatology: Rheumatoid Arthritis; Spondyloarthropothies; Scleroderma and Raynaud’s Disease
Faculty: William T. Ayoub, M.D., F.A.C.P., F.A.C.R., Lawrence H. Brent, M.D.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Rheumatoid Arthritis: Clinical Manifestations and Treatment.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical features of rheumatoid arthritis.
  2. Illustrate the systemic nature of the disease.
  3. Summarize the use and toxicity of disease modifying agents as recommended by the American College of Rheumatology guidelines.

TOPIC 2: Spondyloarthropathies.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
  2. Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
  3. Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

TOPIC 3: Scleroderma and Raynaud’s Disease.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical manifestations of scleroderma.
  2. Apply the ACR/EULAR classification criteria for systemic sclerosis.
  3. Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
  4. Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

Additional information

Format

Hardcopy, Download